Baxter bolsters fill-finish capabilities with $100M investment in Germany

Baxter International (NYSE:BAX) plans to invest roughly $100 million to expand a sterile fill-finish manufacturing plant in Halle/Westfalen, Germany.

BioPharma Solutions (BPS), a subsidiary of Deerfield, Illinois–based Baxter, will manage the new facility.

BPS supports pharmaceutical companies through a range of offerings, including scientific support, sterile contract manufacturing and parenteral delivery systems.

Get the full story from our sister site, Pharmaceutical Processing World. 

Read more
  • 0